drs. B. van Essen-Eisses

Faculty of Medical Sciences

Telephone:

E-mail:

b.eisses umcg.nl

Research Portal

Publications

Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer

IMPACT-Metastatic Breast Consortium, Boers, J., Eisses, B., Zwager, M. C., van Geel, J. J. L., Bensch, F., de Vries, E. F. J., Hospers, G. A. P., Glaudemans, A. W. J. M., Brouwers, A. H., den Dekker, M. A. M., Elias, S. G., Kuip, E. J. M., van Herpen, C. M. L., Jager, A., van der Veldt, A. A. M., Oprea-Lager, D. E., de Vries, E. G. E., van der Vegt, B. & Menke-van der Houven van Oordt, W. C. & 1 others, Schröder, C. P., 14-Feb-2024, In: Diagnostics. 14, 4, 14 p., 416.

Research output: Contribution to journal › Article › Academic › peer-review

Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer

Eisses, B., van Geel, J. J. L., Brouwers, A. H., Bensch, F., Elias, S. G., Kuip, E. J. M., Jager, A., van der Vegt, B., Lub-de Hooge, M. N., Emmering, J., Arens, A. I. J., Zwezerijnen, G. J. C., Vugts, D. J., Menke-van der Houven van Oordt, C. W., de Vries, E. G. E. & Schröder, C. P., Oct-2024, In: Journal of Nuclear Medicine. 65, 10, p. 1540-1547 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to predict watchful waiting duration in patients with metastatic clear cell renal cell carcinoma

Verhoeff, S. R., Oosting, S. F., Elias, S. G., van Es, S. C., Gerritse, S. L., Angus, L., Heskamp, S., Desar, I. M. E., Menke-van der Houven van Oordt, C. W., van der Veldt, A. A. M., Arens, A. I. J., Brouwers, A. H., Eisses, B., Mulders, P. F. A., Hoekstra, O. S., Zwezerijnen, G. J. C., van der Graaf, W. T. A., Aarntzen, E. H. J. G., Oyen, W. J. G. & van Herpen, C. M. L., 1-Feb-2023, In: Clinical Cancer Research. 29, 3, p. 592–601 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Non-invasive estrogen receptor assessment by [F-18]-fluorestradiol(FES)-PET or circulating tumor cells predicts receptor status in patients with metastatic breast cancer

Eisses, B., Angus, L., van der Vegt, B., Sieuwerts, A. M., Kraan, J., Martens, J. W., Glaudemans, A. W., Brouwers, A. H., Hoekstra, O. S., Oyen, W., Emmering, J., Gerritse, S., van Oordt, C. W.M.-V. D. H., Boon, E., van Herpen, C. M., Jager, A., Sleijfer, S., de Vries, E. G. & Schröder, C. P., Feb-2019, In: Cancer Research. 79, 4, 3 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Molecular Imaging in Cancer Drug Development

Waaijer, S. J. H., Kok, I. C., Eisses, B., Schröder, C. P., Jalving, M., Brouwers, A. H., Lub-de Hooge, M. N. & de Vries, E. G. E., May-2018, In: Journal of Nuclear Medicine. 59, 5, p. 726-732 8 p.

Research output: Contribution to journal › Editorial › Academic › peer-review

Reflections on a Research Clerkship Abroad

Eisses, B., de Vries, J. & Chang, S., 11-Jul-2015, In: Journal of Cancer Education.

Research output: Contribution to journal › Article › Academic › peer-review

All (6) publications

View full research profile